Egalet-002

Egalet’s extended-release, abuse-deterrent opioid succeeds in Ph3 trial
Drug Delivery Business News
Tue, 11/28/17 - 10:01 am
Egalet
abuse-resistant painkillers
clinical trials
opioids
Egalet-002